CIK 0001818844 · Non-accelerated filer<br>Smaller reporting company
Dogwood Therapeutics, Inc.
Sign in to watch- Ticker
- DWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 854314201
- Phone
- 8666208655
- Business address
- 44 MILTON AVENUE, ALPHARETTA, GA, 30009
- Former names
- Virios Therapeutics, Inc., Virios Therapeutics, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-03 | Pridgen William Director | Purchase | +2,215 | $5.43 | $12K | 14,542 |
| 2021-12-23 | Whitley Richard James Director | Purchase | +200 | $5.73 | $1K | 200 |
| 2021-12-21 | Pridgen William Director | Purchase | +8,827 | $5.66 | $50K | 12,327 |
| 2021-12-21 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Purchase | +5,000 | $5.52 | $28K | 24,961 |
| 2021-07-07 | Pridgen William Director | Purchase | +942 | $6.32 | $6K | 710,734 |
| 2021-06-22 | Pridgen William Director | Grant or award · Stock Option (right to buy) | +7,875 | 7,875 | ||
| 2021-06-22 | Burch Richard Alan Director | Grant or award · Stock Option (right to buy) | +7,875 | 7,875 | ||
| 2021-06-22 | Whitley Richard James Director | Grant or award · Stock Option (right to buy) | +7,875 | 7,875 | ||
| 2021-06-22 | Thomas John C Director | Grant or award · Stock Option (right to buy) | +7,875 | 7,875 | ||
| 2021-06-22 | Keefer David R Director | Grant or award · Stock Option (right to buy) | +7,875 | 7,875 | ||
| 2021-06-22 | De La Rosa Abel Director | Grant or award · Stock Option (right to buy) | +7,875 | 7,875 | ||
| 2021-06-21 | Walsh Angela SVP OF FINANCE | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-06-21 | Grosswald Ralph VICE PRESIDENT OF OPERATIONS | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-06-21 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2021-04-06 | Duncan Gregory Scott Chief Executive Officer | Purchase | +382 | $6.36 | $2K | 19,961 |
| 2021-04-05 | Duncan Gregory Scott Chief Executive Officer | Purchase | +15,675 | $6.17 | $97K | 19,579 |
| 2021-04-05 | Duncan Gregory Scott Chief Executive Officer | Purchase | +15,675 | $6.17 | $97K | 19,579 |
| 2021-01-29 | Pridgen William Director | Purchase | +3,500 | $7.47 | $26K | 3,500 |
| 2021-01-28 | Walsh Angela VP of Finance | Purchase | +1,000 | $7.30 | $7K | 1,000 |
| 2021-01-28 | Pridgen William Director | Option exercise | +801 | $7.80 | $6K | 727,993 |
Page 5 of 6 · 113 trades